 | • レポートコード：GIR-107A14897 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、全細胞コレラワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全細胞コレラワクチンの種類別市場規模（大人用、子供用）、用途別市場規模（臨床研究所、病院、外科センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・全細胞コレラワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：SBL Vaccine、PaxVax、Valneva SE、GlaxoSmithKline、Johnson and Johnson、Merck、Pfizer、Sanofi Pasteur、AstraZeneca(Medimmune, LLC.)、Serum Institute of India ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：大人用、子供用 ・用途別分析2016年-2026年：臨床研究所、病院、外科センター、その他 ・全細胞コレラワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・全細胞コレラワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・全細胞コレラワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・全細胞コレラワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・全細胞コレラワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Whole Cell Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Whole Cell Cholera Vaccine size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Whole Cell Cholera Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Whole Cell Cholera Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
For Adults
For Children
Market segment by Application can be divided into
Clinical Research Institutes
Hospital
Surgical Centers
Others
The key market players for global Whole Cell Cholera Vaccine market are listed below:
SBL Vaccine
PaxVax
Valneva SE
GlaxoSmithKline
Johnson and Johnson
Merck
Pfizer
Sanofi Pasteur
AstraZeneca(Medimmune, LLC.)
Serum Institute of India
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Whole Cell Cholera Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Whole Cell Cholera Vaccine, with price, sales, revenue and global market share of Whole Cell Cholera Vaccine from 2019 to 2021.
Chapter 3, the Whole Cell Cholera Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Whole Cell Cholera Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Whole Cell Cholera Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Whole Cell Cholera Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Whole Cell Cholera Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Whole Cell Cholera Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 For Adults
1.2.3 For Children
1.3 Market Analysis by Application
1.3.1 Overview: Global Whole Cell Cholera Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinical Research Institutes
1.3.3 Hospital
1.3.4 Surgical Centers
1.3.5 Others
1.4 Global Whole Cell Cholera Vaccine Market Size & Forecast
1.4.1 Global Whole Cell Cholera Vaccine Sales in Value (2016-2026))
1.4.2 Global Whole Cell Cholera Vaccine Sales in Volume (2016-2026)
1.4.3 Global Whole Cell Cholera Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Whole Cell Cholera Vaccine Production Capacity Analysis
1.5.1 Global Whole Cell Cholera Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Whole Cell Cholera Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Whole Cell Cholera Vaccine Market Drivers
1.6.2 Whole Cell Cholera Vaccine Market Restraints
1.6.3 Whole Cell Cholera Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 SBL Vaccine
2.1.1 SBL Vaccine Details
2.1.2 SBL Vaccine Major Business
2.1.3 SBL Vaccine Whole Cell Cholera Vaccine Product and Services
2.1.4 SBL Vaccine Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 PaxVax
2.2.1 PaxVax Details
2.2.2 PaxVax Major Business
2.2.3 PaxVax Whole Cell Cholera Vaccine Product and Services
2.2.4 PaxVax Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Valneva SE
2.3.1 Valneva SE Details
2.3.2 Valneva SE Major Business
2.3.3 Valneva SE Whole Cell Cholera Vaccine Product and Services
2.3.4 Valneva SE Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Whole Cell Cholera Vaccine Product and Services
2.4.4 GlaxoSmithKline Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Johnson and Johnson
2.5.1 Johnson and Johnson Details
2.5.2 Johnson and Johnson Major Business
2.5.3 Johnson and Johnson Whole Cell Cholera Vaccine Product and Services
2.5.4 Johnson and Johnson Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Whole Cell Cholera Vaccine Product and Services
2.6.4 Merck Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Whole Cell Cholera Vaccine Product and Services
2.7.4 Pfizer Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Sanofi Pasteur
2.8.1 Sanofi Pasteur Details
2.8.2 Sanofi Pasteur Major Business
2.8.3 Sanofi Pasteur Whole Cell Cholera Vaccine Product and Services
2.8.4 Sanofi Pasteur Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 AstraZeneca(Medimmune, LLC.)
2.9.1 AstraZeneca(Medimmune, LLC.) Details
2.9.2 AstraZeneca(Medimmune, LLC.) Major Business
2.9.3 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product and Services
2.9.4 AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Serum Institute of India
2.10.1 Serum Institute of India Details
2.10.2 Serum Institute of India Major Business
2.10.3 Serum Institute of India Whole Cell Cholera Vaccine Product and Services
2.10.4 Serum Institute of India Whole Cell Cholera Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Whole Cell Cholera Vaccine Sales by Manufacturer
3.1 Global Whole Cell Cholera Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Whole Cell Cholera Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Whole Cell Cholera Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Whole Cell Cholera Vaccine Manufacturer Market Share
3.4.2 Top 6 Whole Cell Cholera Vaccine Manufacturer Market Share
3.5 Global Whole Cell Cholera Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Whole Cell Cholera Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Whole Cell Cholera Vaccine Market Size by Region
4.1.1 Global Whole Cell Cholera Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Whole Cell Cholera Vaccine Revenue by Region (2016-2026)
4.2 North America Whole Cell Cholera Vaccine Revenue (2016-2026)
4.3 Europe Whole Cell Cholera Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Whole Cell Cholera Vaccine Revenue (2016-2026)
4.5 South America Whole Cell Cholera Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Whole Cell Cholera Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Whole Cell Cholera Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Whole Cell Cholera Vaccine Revenue by Type (2016-2026)
5.3 Global Whole Cell Cholera Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Whole Cell Cholera Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Whole Cell Cholera Vaccine Revenue by Application (2016-2026)
6.3 Global Whole Cell Cholera Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Whole Cell Cholera Vaccine Sales by Type (2016-2026)
7.2 North America Whole Cell Cholera Vaccine Sales by Application (2016-2026)
7.3 North America Whole Cell Cholera Vaccine Market Size by Country
7.3.1 North America Whole Cell Cholera Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Whole Cell Cholera Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Whole Cell Cholera Vaccine Sales by Type (2016-2026)
8.2 Europe Whole Cell Cholera Vaccine Sales by Application (2016-2026)
8.3 Europe Whole Cell Cholera Vaccine Market Size by Country
8.3.1 Europe Whole Cell Cholera Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Whole Cell Cholera Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Whole Cell Cholera Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Whole Cell Cholera Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Whole Cell Cholera Vaccine Market Size by Region
9.3.1 Asia-Pacific Whole Cell Cholera Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Whole Cell Cholera Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Whole Cell Cholera Vaccine Sales by Type (2016-2026)
10.2 South America Whole Cell Cholera Vaccine Sales by Application (2016-2026)
10.3 South America Whole Cell Cholera Vaccine Market Size by Country
10.3.1 South America Whole Cell Cholera Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Whole Cell Cholera Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Whole Cell Cholera Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Whole Cell Cholera Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Whole Cell Cholera Vaccine Market Size by Country
11.3.1 Middle East & Africa Whole Cell Cholera Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Whole Cell Cholera Vaccine Typical Distributors
12.3 Whole Cell Cholera Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Whole Cell Cholera Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Whole Cell Cholera Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. SBL Vaccine Basic Information, Manufacturing Base and Competitors
Table 4. SBL Vaccine Major Business
Table 5. SBL Vaccine Whole Cell Cholera Vaccine Product and Services
Table 6. SBL Vaccine Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. PaxVax Basic Information, Manufacturing Base and Competitors
Table 8. PaxVax Major Business
Table 9. PaxVax Whole Cell Cholera Vaccine Product and Services
Table 10. PaxVax Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Valneva SE Basic Information, Manufacturing Base and Competitors
Table 12. Valneva SE Major Business
Table 13. Valneva SE Whole Cell Cholera Vaccine Product and Services
Table 14. Valneva SE Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Whole Cell Cholera Vaccine Product and Services
Table 18. GlaxoSmithKline Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson and Johnson Major Business
Table 21. Johnson and Johnson Whole Cell Cholera Vaccine Product and Services
Table 22. Johnson and Johnson Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merck Basic Information, Manufacturing Base and Competitors
Table 24. Merck Major Business
Table 25. Merck Whole Cell Cholera Vaccine Product and Services
Table 26. Merck Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Whole Cell Cholera Vaccine Product and Services
Table 30. Pfizer Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Pasteur Major Business
Table 33. Sanofi Pasteur Whole Cell Cholera Vaccine Product and Services
Table 34. Sanofi Pasteur Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. AstraZeneca(Medimmune, LLC.) Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca(Medimmune, LLC.) Major Business
Table 37. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Product and Services
Table 38. AstraZeneca(Medimmune, LLC.) Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 40. Serum Institute of India Major Business
Table 41. Serum Institute of India Whole Cell Cholera Vaccine Product and Services
Table 42. Serum Institute of India Whole Cell Cholera Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Whole Cell Cholera Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Whole Cell Cholera Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Whole Cell Cholera Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Whole Cell Cholera Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Whole Cell Cholera Vaccine Production Site of Key Manufacturer
Table 48. Whole Cell Cholera Vaccine New Entrant and Capacity Expansion Plans
Table 49. Whole Cell Cholera Vaccine Mergers & Acquisitions in the Past Five Years
Table 50. Global Whole Cell Cholera Vaccine Sales by Region (2016-2021e) & (K Units)
Table 51. Global Whole Cell Cholera Vaccine Sales by Region (2021-2026) & (K Units)
Table 52. Global Whole Cell Cholera Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Whole Cell Cholera Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Whole Cell Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 55. Global Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 56. Global Whole Cell Cholera Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Whole Cell Cholera Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Whole Cell Cholera Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Whole Cell Cholera Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Whole Cell Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 61. Global Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 62. Global Whole Cell Cholera Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Whole Cell Cholera Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Whole Cell Cholera Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Whole Cell Cholera Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Whole Cell Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 67. North America Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 68. North America Whole Cell Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Whole Cell Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Whole Cell Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 71. North America Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 72. North America Whole Cell Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 73. North America Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 74. Europe Whole Cell Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 76. Europe Whole Cell Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Whole Cell Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Whole Cell Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 80. Europe Whole Cell Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Whole Cell Cholera Vaccine Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Whole Cell Cholera Vaccine Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Whole Cell Cholera Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Whole Cell Cholera Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Whole Cell Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Whole Cell Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 90. South America Whole Cell Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 91. South America Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 92. South America Whole Cell Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Whole Cell Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Whole Cell Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 95. South America Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 96. South America Whole Cell Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 97. South America Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Whole Cell Cholera Vaccine Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Whole Cell Cholera Vaccine Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Whole Cell Cholera Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Whole Cell Cholera Vaccine Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Whole Cell Cholera Vaccine Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Whole Cell Cholera Vaccine Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Whole Cell Cholera Vaccine Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Whole Cell Cholera Vaccine Typical Distributors
Table 109. Whole Cell Cholera Vaccine Typical Customers
List of Figures
Figure 1. Whole Cell Cholera Vaccine Picture
Figure 2. Global Whole Cell Cholera Vaccine Sales Market Share by Type in 2020
Figure 3. For Adults
Figure 4. For Children
Figure 5. Global Whole Cell Cholera Vaccine Sales Market Share by Application in 2020
Figure 6. Clinical Research Institutes
Figure 7. Hospital
Figure 8. Surgical Centers
Figure 9. Others
Figure 10. Global Whole Cell Cholera Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Whole Cell Cholera Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Whole Cell Cholera Vaccine Sales (2016-2026) & (K Units)
Figure 13. Global Whole Cell Cholera Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global Whole Cell Cholera Vaccine Production Capacity (2016-2026) & (K Units)
Figure 15. Global Whole Cell Cholera Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Whole Cell Cholera Vaccine Market Drivers
Figure 17. Whole Cell Cholera Vaccine Market Restraints
Figure 18. Whole Cell Cholera Vaccine Market Trends
Figure 19. Global Whole Cell Cholera Vaccine Sales Market Share by Manufacturer in 2020
Figure 20. Global Whole Cell Cholera Vaccine Revenue Market Share by Manufacturer in 2020
Figure 21. Whole Cell Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Whole Cell Cholera Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Whole Cell Cholera Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Whole Cell Cholera Vaccine Sales Market Share by Region (2016-2026)
Figure 25. Global Whole Cell Cholera Vaccine Revenue Market Share by Region (2016-2026)
Figure 26. North America Whole Cell Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 27. Europe Whole Cell Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Whole Cell Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 29. South America Whole Cell Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Whole Cell Cholera Vaccine Revenue (2016-2026) & (USD Million)
Figure 31. Global Whole Cell Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 32. Global Whole Cell Cholera Vaccine Revenue Market Share by Type (2016-2026)
Figure 33. Global Whole Cell Cholera Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global Whole Cell Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 35. Global Whole Cell Cholera Vaccine Revenue Market Share by Application (2016-2026)
Figure 36. Global Whole Cell Cholera Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America Whole Cell Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 38. North America Whole Cell Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 39. North America Whole Cell Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 40. North America Whole Cell Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 41. United States Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Whole Cell Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 45. Europe Whole Cell Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 46. Europe Whole Cell Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 47. Europe Whole Cell Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 48. Germany Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Whole Cell Cholera Vaccine Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Whole Cell Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Whole Cell Cholera Vaccine Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Whole Cell Cholera Vaccine Revenue Market Share by Region (2016-2026)
Figure 57. China Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Whole Cell Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 64. South America Whole Cell Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 65. South America Whole Cell Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 66. South America Whole Cell Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Whole Cell Cholera Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Whole Cell Cholera Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Whole Cell Cholera Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界の遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 世界の糖衣錠キャンディー（サル肝細胞）におけるポリオワクチン市場 2021：企業別、地域別、種類・用途別 The Poliomycetes Vaccine in Dragee Candy (Monkey Liver Cell) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 世界の帯状疱疹生ワクチン市場 2021：企業別、地域別、種類・用途別 The Zoster Vaccine Live market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の髄膜炎菌感染症ワクチン市場 2021：企業別、地域別、種類・用途別 The Meningococcal Infections Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…